For Hodgkin Lymphoma, Robust Treatment Options Keep Hope Alive

Dr. Ajay Gopal discusses his optimism at the state of the treatment for Hodgkin Lymphoma, a disease that primarily affects young adults. For the newly diagnosed, he assures us that the standard therapies for the disease have been incredibly successful and most patients will be cured with the first treatment regimen. For those that are not, Dr. Gopal covers the range of options including autologous transplant and the expanding use of allogeneic transplant, made possible by the newly approved brentuximab vedotin (Adcetris).